Cubist Systematic Strategies, LLC Beam Therapeutics Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$23.46 - $45.07 $1.71 Million - $3.28 Million	72,721 Added 855.64%	81,220 $2.68 Million
Q4 2023 Feb 14, 2024	BUY	$17.69 - $30.76 $150,347 - $261,429	8,499 New	8,499 $231,000
Q2 2023 Aug 14, 2023	SELL	$29.32 - $35.99 $171,082 - $210,001	-5,835 Reduced 37.06%	9,909 $316,000
Q1 2023 May 15, 2023	SELL	$30.15 - $48.79 $962,840 - $1.56 Million	-31,935 Reduced 66.98%	15,744 $482,000
Q4 2022 Feb 14, 2023	SELL	$36.73 - $51.6 $1.08 Million - $1.52 Million	-29,423 Reduced 38.16%	47,679 $1.86 Million
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $5.07 Million - $8.95 Million	-127,353 Reduced 62.29%	77,102 $3.67 Million
Q2 2022 Aug 15, 2022	BUY	$29.86 - $62.36 $3.15 Million - $6.58 Million	105,515 Added 106.65%	204,455 $7.91 Million
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $5.06 Million - $7.74 Million	94,152 Added 1966.42%	98,940 $5.67 Million
Q4 2021 Feb 14, 2022	SELL	$68.02 - $99.06 $1.15 Million - $1.67 Million	-16,867 Reduced 77.89%	4,788 $382,000
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $1.83 Million - $2.89 Million	21,655 New	21,655 $1.88 Million
Q2 2021 Aug 16, 2021	SELL	$64.12 - $128.71 $1.09 Million - $2.18 Million	-16,953 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$71.28 - $120.75 $1.21 Million - $2.05 Million	16,953 New	16,953 $1.36 Million
Q4 2020 Feb 16, 2021	SELL	$22.24 - $95.63 $13,343 - $57,378	-600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$19.0 - $30.57 $3,800 - $6,114	200 Added 50.0%	600 $15,000
Q2 2020 Aug 14, 2020	BUY	$15.26 - $28.66 $6,104 - $11,464	400 New	400 $11,000

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

Farallon Capital Management LLC San Francisco, CA

8.21M
Shares

$208 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.84M
Shares

$198 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.63M
Shares

$193 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

6.53M
Shares

$165 Million
1.52% of portfolio
Arch Venture Management, LLC Chicago, IL

4.83M
Shares

$122 Million
71.21% of portfolio

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account